IJInga Maria Johannsdottir

Inga Maria Johannsdottir

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Inga Maria Johannsdottir has a total of 13 co-authors. Here are the top co-authors by number of shared publications:

  • Jon H. Loge

    Department of Oncology, Regional Advisory Unit for Palliative Care, Oslo University Hospital, Oslo, Norway

    4 shared publications
  • Finn Wesenberg

    Division of Pediatrics, Oslo University Hospital, Rikshospitalet, Oslo, Norway

    3 shared publications
  • Gudmundur Jónmundsson

    Department of Pediatrics, Landspitalinn, Reykjavik, Iceland

    3 shared publications
  • Henrik Schrøder

    Department of Pediatrics, University Hospital of Aarhus, Skejby, Aarhus, Denmark

    3 shared publications
  • Lars Hjorth

    Department of Pediatrics, Skåne University Hospital, Lund, Sweden

    3 shared publications
  • Marianne J. Hjermstad

    Regional Centre for Excellence in Palliative Care, Department of Oncology, Oslo University Hospital, Ullevål, Oslo, Norway

    3 shared publications

Latest Publications

  • Increased prescription rates of anxiolytics and hypnotics to survivors of cancer in childhood, adolescence, and young adulthood—A population‐based study

    by Inga Maria Johannsdottir, Jon H. Loge, Cecilie E. Kiserud, Øystein Karlstad, Svetlana Skurtveit

    Background: Survivors of cancer diagnosed in childhood, adolescence, or young adulthood (CAYACS) risk psychological morbidities later in life. The study compares prescription rates of anxiolytics and hypnotics among survivors to rates in age‐ and gender‐matched controls.Procedures: The population‐based cohort included 5,341 cancer survivors, diagnosed ≤25 years of age during 1965–2000. For each survivor, three age‐ and gender‐matched controls were randomly selected from the general population. Data were identified from the Norwegian Cancer and Population registries and linked to the Norwegian Prescription Database. A Cox proportional hazard model was applied to estimate hazard ratios (HRs) of prescriptions during 2004–2012 to the survivors with controls as referents.Results: Survivors had an increased risk of being prescribed anxiolytics with crude rates of 16.9/1,000 person years compared to 11.8/1,000 person years in controls (HR 1.41; 95% confidence interval [CI] 1.29–1.54). The relative risk was highest for survivors of neuroblastomas (HR 2.62; 95% CI 1.11–6.16), bone tumors (HR 2.00; 95% CI 1.26–3.18), and central nervous system tumors (HR 1.90; 95% CI 1.40–2.51). The risk of being prescribed hypnotics was increased with crude rates of 20.8/1,000 person years compared to 14.3/1,000 person years in controls (HR 1.44; 95% CI 1.32–1.56). The relative risk was highest for survivors of gastrointestinal tumors (HR 1.80; 95% CI 1.04–3.10), leukemias (HR 1.78; 95% CI 1.32–2.38), and soft tissue cancers (HR 1.70; 95% CI 1.09–2.64).Conclusions: Certain groups of CAYACS have an increased risk for being prescribed anxiolytics or hypnotics compared to controls. Diagnostic reasons for prescriptions are unknown, but the results indicate an increased emotional burden among these groups of survivors.


  • Emotional Functioning and School Contentment in Adolescent Survivors of Acute Myeloid Leukemia, Infratentorial Astrocytoma, and Wilms Tumor

    by Inga M. Jóhannsdóttir, Torbjørn Moum, Marianne J. Hjermstad, Finn Wesenberg, Lars Hjorth, Henrik Schrøder, Päivi M. Lähteenmäki, Gudmundur Jónmundsson, Jon H. Loge

    Purpose: Cancer in childhood may disrupt normal developmental processes and cause psychosocial problems in adolescent survivors of childhood cancers (ACCSs). Previous studies report inconsistent findings. Study aims were to assess subjective well-being (SWB), psychological distress, and school contentment in survivors of three dissimilar childhood cancers. Patients and methods: Nordic patients treated for acute myeloid leukemia (AML), infratentorial astrocytoma (IA), and Wilms tumor (WT) in childhood from 1985 to 2001, aged ≥1 year at diagnosis, and aged 13–18 years at the time of study were eligible for this questionnaire-based survey that included items on SWB, psychological distress, school contentment, self-esteem, and personality traits; 65% (151/231) responded. An age-equivalent group from a Norwegian health survey (n=7910) served as controls. Results: The median age of ACCSs was 16 years; 52% were males. ACCSs reported better SWB (p=0.004) and self-esteem (pp=0.004) and their school contentment tended to be higher than controls. SWB and school contentment were positively influenced by self-esteem. However, ACCSs reported higher levels of psychological distress (p=0.002), mostly attributable to general worrying. No significant differences in outcomes were found across diagnoses, and time since diagnosis did not significantly affect the results. Conclusion: The overall emotional functioning of ACCSs was good, possibly due to changes in their perception of well-being after having survived a life-threatening disease. However, they seemed more worried than their peers. This may cause an additional strain at a vulnerable period in life.


  • Increased prevalence of chronic fatigue among survivors of childhood cancers: A population‐based study

    by Inga M.R. Jóhannsdóttir, Marianne J. Hjermstad, Torbjørn Moum, Finn Wesenberg, Lars Hjorth, Henrik Schrøder, Susanna Mört, Gudmundur Jónmundsson, Jon H. Loge

    Background: Fatigue is prevalent in adult cancer survivors but less studied in childhood cancer survivors. Aims were to assess fatigue levels, prevalence of chronic fatigue (CF) and the association of CF with health‐related quality of life (HRQoL) in survivors of acute myeloid leukemia (AML), infratentorial astrocytoma (IA), and Wilms tumor (WT) in childhood.Procedure: Seventy percent (398/567) of Nordic patients treated for AML, IA, and WT between 1985 and 2001 at age >1 year responded to a postal survey, encompassing the Fatigue Questionnaire and the Short Form 36 (SF‐36). Participants were divided into two groups at time of study; younger (YG, 13–18 years) and older (OG, 19–34 years). Respondents (19–34 years, n = 763) from a Norwegian general population (GP) survey served as controls for the OG.Results: The OG [mean age was 24 years (SD 3.3)] had higher fatigue levels compared to the YG and the GP, especially the females (P < 0.05). There was also a higher prevalence of CF in the OG than in the GP (14 vs. 6%, P < 0.001). Regardless of diagnosis, the OG with CF had poorer physical health (P < 0.05) on the SF‐36 but better mental health (P < 0.05 and P = 0.001) relative to controls with CF.Conclusions: The prevalence of CF is higher among Nordic survivors of AML, IA, and WT than GP controls of similar age. CF is associated with impaired HRQoL in survivors. However, they reported better mental health than CF GP controls. This might indicate different underlying mechanisms of CF in the two populations. Pediatr Blood Cancer 2012; 58: 415–420.


  • Social outcomes in young adult survivors of low incidence childhood cancers

    by Inga M. R. Jóhannsdóttir, Marianne J. Hjermstad, Torbjørn Moum, Finn Wesenberg, Lars Hjorth, Henrik Schrøder, Päivi Lähteenmäki, Gudmundur Jónmundsson, Jon H. Loge

    The intensity and duration of childhood cancer treatment may disrupt psychosocial development and thereby cause difficulties in transition into adulthood. The study objective was to assess social outcomes in early adulthood after successful treatment for childhood acute myeloid leukemia (AML), Wilms tumor (WT) and infratentorial astrocytoma (IA). Nordic patients treated for AML, WT and IA from 1985 to 2001 identified from a database administered by NOPHO (Nordic Society of Paediatric Haematology and Oncology) were invited to participate in a postal survey. All cancer-free survivors treated at age >1 year who were >19 years at time of study were eligible. Seventy-four percent; 247/335 responded. An age-equivalent group (N = 1,814) from a Norwegian Census Study served as controls. Mean age of survivors was 23 years (range 19–34), 55% females. The proportion with academic education (≥4 years) was similar in survivors and controls (28 vs. 32%). Fifty-nine percent of survivors were employed compared to 77% among controls (p < .01). More survivors were recipients of social benefits (6.7 vs. 3.1%, p < .01). There were no differences in marital status but parenthood was more common among controls (37 vs. 27%, p = .01). Controls lived longer in their parental homes (p = .01). Cancer type or treatment intensity had no statistically significant impact on results, except for parenthood. The study revealed important differences in social outcomes between survivors and controls early in adult life. Specific difficulties pertain to studying social status in early adulthood because of the natural transition characteristics for this age group. Therefore, longer follow-up is warranted.